| Literature DB >> 25198102 |
Agnieszka Laszkiewicz1, Łukasz Bzdzion1, Monika Kasztura1, Lukasz Snieżewski1, Sylwia Janik1, Paweł Kisielow1, Małgorzata Cebrat1.
Abstract
Recombination activating gene-2 (RAG-2) and NWC are strongly evolutionarily conserved overlapping genes which are convergently transcribed. In non-lymphoid cells the NWC promoter is active whereas in lymphocytes it is inactive due to the DNA methylation. Analysing the mechanism responsible for lymphocyte-specific methylation and inactivation of NWC promoter we found that Ikaros, a lymphocyte-specific transcription factor, acts as a repressor of NWC promoter--thus identifying a new Ikaros target--but is insufficient for inducing its methylation which depends on the antisense transcription driven by RAG-2 promoter. Possible implications of these observations for understanding evolutionary mechanisms leading to lymphocyte specific expression of RAG genes are discussed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25198102 PMCID: PMC4157847 DOI: 10.1371/journal.pone.0106927
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Ikaros-binding properties of NWC promoter.
(A) Structure of RAG/NWC locus and NWC gene promoter. Open gray and black boxes represent NWC, RAG-2 and RAG-1 exons, respectively. Horizontal arrows indicate the directions of the transcription and the numbers indicate the position of the sequences relative to NWC transcriptional start site. Red line indicates the localization of the EMSA probe (−119/+12) lying within the NWC promoter (−119/+125). Aligned sequences of murine (Mus musculus) and human (Homo sapiens) NWC promoters are shown. The sequence logos represent ZFP-143 binding sites and putative Ikaros binding sites. Vertical arrows indicate the location and nature of the mutations introduced in probes and reporter constructs used throughout this study. (B) EMSA experiment showing Ikaros binding to NWC promoter: first lane from the left – free probe, second – probe and Ikaros, next – probe, Ikaros and increasing molar excess (10, 50, 100x) of unlabelled specific (lanes 3–5) or non-specific competitors (Oct-2, for sequence see Materials and Methods) (lanes 6–9). (C) EMSA experiment showing Ikaros binding to non-mutated (NM), single mutated (mutA, mutT) or double mutated (mutAT) NWC promoter. Probes were tested in the absence (−) and presence (+) of Ikaros. (D) Competition of ZFP-143 and Ikaros for NWC promoter binding. Constant amount (150 ng) of ZFP-143 protein and increasing amount of Ikaros protein (Ikaros/ZFP-143 molar ratio: 0, 0.3, 0.5, 1, 1.5, 2, 2.5, 3, lanes 2–8) were used to bind to the probe corresponding to non-mutated NWC promoter.
Figure 2Ikaros downregulates the activity of NWC promoter.
(A) Real-Time RT-PCR analysis of endogenous NWC expression in non-lymphoid cells (HEK293T) transfected with Ikaros-expressing construct (pLVX-Ikaros-IRES-ZsGreen) or with empty vector (pLVX-IRES-ZsGreen) (100%). Transfection efficiency varied and approximated 80%. The MFI after sorting was ∼1300. Expression values were normalized to GAPDH. The results shown are the means of three experiments with error bars representing ±1 SD. The asterisk indicates a significant difference (p<0.05) between both sample groups. (B) Activity of NWC promoter fragments containing point mutations in the Ikaros/ZFP-143 binding sites tested by luciferase assay in HEK293T cells ectopically expressing Ikaros gene (white bars) or transfected with empty vector (grey bars). pNWC-NM: non-mutated binding sites, pNWC-mGC: mutation specifically affecting the Ikaros binding site (see C), pNWC-mAT: mutation affecting both Ikaros and ZFP-143 binding sites. The relative promoter activities were normalized to the activity of promoter-less vector (pGL3-Basic). Vector containing SV40 promoter was used as a control. The results shown are the means of three experiments with error bars representing ±1 SD. The asterisk indicates a significant difference (p<0.05) between the activity of the given promoter in the presence or absence of Ikaros expression. (C) EMSA experiments verifying the Ikaros-specific nature of mutations (mGC) introduced to NWC promoter constructs. Non-mutated probes (NM) and probes with mutations affecting both Ikaros and ZFP-143 binding (mAT) were used as controls to monitor the efficiency of Ikaros and ZFP-143 binding.
Figure 3RAG-2 transcription is responsible for NWC promoter methylation.
(A) The RAG/NWC locus of BAC-RG/NY and BAC-RGterm/NY transgenic mice. Relative positions of the exons encoding RAG-1 (black boxes), RAG-2 (open boxes), and NWC (gray boxes) are shown. Horizontal arrows indicate transcription start sites and orientations. Modifications of the locus are presented as green, yellow and red boxes representing GFP, YFP and the transcriptional termination cassette, respectively. (B) Cytofluorimetric evaluation of RAG-2/GFP protein expression in double positive thymocytes (upper histogram) and bone marrow B lymphocytes (middle histogram) and NWC-YFP in testis (lower histogram) of BAC-RGterm/NY (bold line), BAC-RG/NY (normal line) and non-transgenic control (dashed line). (C) Methylation status of transgenic NWC promoter of control (grey bars) and RAG-2 terminator-containing (white bars) loci.